Bruce Neal's Publications

About Bruce Neal's Publications

Executive Director, The George Institute for Global Health, Australia
  • Canagliflozin and atrial fibrillation in type 2 diabetes mellitus: A secondary analysis from the CANVAS Program and CREDENCE trial and meta-analysis

    Diabetes, Obesity and Metabolism Date published:
  • 19-OR: KidneyIntelX Association with Clinical Outcomes in Diabetic Kidney Disease

    Diabetes Date published:
  • Cost-Effectiveness of a Household Salt Substitution Intervention: Findings From 20 995 Participants of the Salt Substitute and Stroke Study

    Circulation Date published:
  • 2022 World Hypertension League, Resolve To Save Lives and International Society of Hypertension dietary sodium (salt) global call to action

    Journal of Human Hypertension Date published:
  • Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Hyperkalemia in People With Type 2 Diabetes: A Meta-Analysis of Individual Participant Data From Randomized, Controlled Trials

    Circulation Date published:
  • Cardiovascular and renal outcomes with canagliflozin in patients with peripheral arterial disease: Data from the CANVAS Program and CREDENCE trial

    Diabetes, Obesity and Metabolism Date published:
  • Clinical Utility of KidneyIntelX in Early Stages of Diabetic Kidney Disease in the CANVAS Trial

    American Journal of Nephrology Date published:
  • EFFECTS OF SALT SUBSTITUTES ON BLOOD PRESSURE AND CLINICAL OUTCOMES IN DIFFERENT POPULATION GROUPS: A SYSTEMATIC REVIEW AND META-ANALYSIS

    Journal of the American College of Cardiology Date published:
  • The sodium hidden in medication: a tough pill to swallow

    European Heart Journal Date published:
  • Canagliflozin and Kidney-Related Adverse Events in Type 2 Diabetes and CKD: Findings From the Randomized CREDENCE Trial

    American Journal of Kidney Diseases Date published:
  • The Contribution of Major Food Categories and Companies to Household Purchases of Added Sugar in Australia

    Journal of the Academy of Nutrition and Dietetics Date published:
  • Association between TNF Receptors and KIM-1 with Kidney Outcomes in Early-Stage Diabetic Kidney Disease

    Clinical Journal of the American Society of Nephrology Date published:
  • POS-392 CANAGLIFLOZIN TREATMENT IMPACTS COLLAGEN TYPE III DEGRADATION AND FORMATION IN THE CANAGLIFLOZIN CARDIOVASCULAR ASSESSMENT STUDY (CANVAS)

    Kidney International Reports Date published:
  • Stress Cardiac Biomarkers, Cardiovascular and Renal Outcomes, and Response to Canagliflozin

    Journal of the American College of Cardiology Date published:
  • Antihypertensive drug effects on long-term blood pressure: an individual-level data meta-analysis of randomised clinical trials

    Heart Date published:
  • A Novel Approach to Estimate Product-Specific Greenhouse Gas Emissions for 23,550 Australian Packaged Foods and Beverages

    SSRN Electronic Journal Date published: